First Time Loading...

argenx SE
NASDAQ:ARGX

Watchlist Manager
argenx SE Logo
argenx SE
NASDAQ:ARGX
Watchlist
Price: 384.465 USD -3.6% Market Closed
Updated: May 9, 2024
Section:
 

Wall Street
Price Targets

ARGX Price Targets Summary
argenx SE

Wall Street analysts forecast ARGX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARGX is 496.808 USD with a low forecast of 180.582 USD and a high forecast of 682.668 USD.

ARGX Lowest Forecast
Wall Street Target
180.582 USD
53% Downside
ARGX Average Forecast
Wall Street Target
496.808 USD
29% Upside
ARGX Highest Forecast
Wall Street Target
682.668 USD
78% Upside
Lowest
Price Target
180.582 USD
53% Downside
Average
Price Target
496.808 USD
29% Upside
Highest
Price Target
682.668 USD
78% Upside
argenx SE Competitors:
Price Targets
M
MLYS
Mineralys Therapeutics Inc
144% Upside
IMCR
Immunocore Holdings PLC
43% Upside
PRQR
ProQR Therapeutics NV
118% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
55% Upside
M
MLYS
Mineralys Therapeutics Inc
144% Upside
IMCR
Immunocore Holdings PLC
43% Upside
PRQR
ProQR Therapeutics NV
118% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
55% Upside
TGTX
TG Therapeutics Inc
91% Upside
S
6955
Shandong Boan Biotechnology Co Ltd
6% Upside
HALO
Halozyme Therapeutics Inc
23% Upside
PTCT
PTC Therapeutics Inc
8% Downside

Revenue
Forecast

Revenue Estimate
argenx SE

For the last 8 years the compound annual growth rate for argenx SE's revenue is 91%. The projected CAGR for the next 3 years is 41%.

91%
Past Growth
41%
Estimated Growth
Estimates Accuracy
-25%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
argenx SE

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
argenx SE

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-26%
Average Miss
What are analyst estimates?

See Also

Summary
ARGX intrinsic value, competitors valuation, and company profile.
DCF Valuation
ARGX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ARGX stock valuation using valuation multiples.
Wall Street Estimates
ARGX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ARGX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ARGX's stock price target?
Price Target
496.808 USD

According to Wall Street analysts, the average 1-year price target for ARGX is 496.808 USD with a low forecast of 180.582 USD and a high forecast of 682.668 USD.

What is argenx SE's Revenue forecast?
Projected CAGR
41%

For the last 8 years the compound annual growth rate for argenx SE's revenue is 91%. The projected CAGR for the next 3 years is 41%.

ALPHA SPREAD
Join more than 135,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.